Advertisement
Screener

Genmab A/S (GNMSF) Increase Decrease In Working Capital

2.8 / 5 stars · 68/120 Roast Me

Genmab A/S Increase Decrease In Working Capital

Genmab A/S (GNMSF) reported Increase Decrease In Working Capital of -DKK 1.36 billion for the 12-month period ending 2023-12-31, per its 6-K filed 2024-02-14.

Discontinued › Notes

ifrs-full:IncreaseDecreaseInWorkingCapital · last filed 2024-02-14

Period endIncrease Decrease In Working Capital 6 monthIncrease Decrease In Working Capital 6 month as first filedIncrease Decrease In Working Capital 12 monthIncrease Decrease In Working Capital 12 month as first filed
2023-12-31-1.36B DKK
6-K · filed 2024-02-14
2023-06-30-1.34B DKK
6-K · filed 2023-08-03
2022-12-311.84B DKK
6-K · filed 2024-02-14
1.93B DKK
6-K · filed 2023-02-22
2022-06-30179.00M DKK
6-K · filed 2023-08-03
2021-12-31705.00M DKK
6-K · filed 2024-02-14
770.00M DKK
6-K · filed 2022-02-16
2021-06-30105.00M DKK
6-K · filed 2022-08-10
2020-12-31-987.00M DKK
6-K · filed 2023-02-22
2020-06-302.57B DKK
6-K · filed 2021-08-11
2019-12-311.22B DKK
6-K · filed 2022-02-16
2019-06-30-700.00M DKK
6-K · filed 2020-08-12
-699.92M DKK
6-K · filed 2019-08-14
2018-12-31634.00M DKK
6-K · filed 2021-02-23
2018-06-30-53.94M DKK
6-K · filed 2019-08-14
2017-12-31-240.00M DKK
20-F · filed 2020-03-30